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The Patient Protection and Affordable Care Act (ACA) addresses use of clinical preventive services relative
to evidence-based guidelines by mandating that most health insurance plans provide coverage without
cost-sharing for services that receive an A or B rating. However, knowledge about and positive attitudes
towards guidelines are extremely low.
This study was a population-based randomized experiment to examine beliefs about and intentions
to adhere to screening guidelines for the Prostate Speciﬁc Antigen (PSA) and Pap tests. The study had two
objectives: (1) test reactions to and understanding of guidelines, and (2) experimentally compare
receptivity to messages to promote PSA and Pap test recommendations. We ﬁrst surveyed a population-
based sample of (1) US adults age 18 and over, (2) subsample of women aged 65 or younger, (3) sub-
sample of men aged 40 or older. A sample of 2923 completed an initial questionnaire. Next a subset of
participants meeting eligibility criteria were recruited from the population-based sample into a message
testing experiment: (1) women aged 65 or younger, (2) and men aged 40 or older. Participants meeting
these eligibility requirements were randomized to gain, loss, or balanced PSA (men) or Pap test (women)
message stimulus conditions and followed for 8 weeks. Data were collected through the GfK Custom
Research panel. A total of 2401 were eligible, 2321 completed the baseline, and 1730 completed
follow up.
Mixed effect regression models revealed that higher receptivity to messages was associated with
greater intentions to seek cancer information and to speak to a Doctor about PSA and Pap tests. The loss
frame was associated with higher intentions to speak to friends and family about PSA and Pap tests.
Finally, perceived importance and personal understanding of guidelines predicted intentions to seek
more information about them.
This study contributes to evidence on how best to inform and engage consumers regarding pre-
ventive services.
& 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Both the underuse and overuse of clinical preventive services
relative to evidence-based guidelines is of signiﬁcant public health
concern. The Patient Protection and Affordable Care Act (ACA)
attempts to address this issue by mandating that most health
insurance plans provide coverage of clinical preventive services,
without cost-sharing, if they receive an A or B rating and are thus
recommended by the United States Preventive Services Task ForceLtd. This is an open access article u
),
ead),
om (J. Snider).(USPSTF). Confusion has arisen around certain screenings that
have been downgraded to a C rating or lower; and consumer
charges that the government is rationing health care have become
more common since passage of the ACA.
Informed consumers are an important foundation of ensuring
the ACA provisions result in both effective and efﬁcient use of
preventive care. However, knowledge about and positive attitudes
toward evidence-based guidelines developed by the USPSTF for
preventive care are extremely low across sociodemographic
groups (Wennberg, 2002; Koh & Sebelius, 2010). Given demon-
strated low levels of consumer knowledge of and trust in guide-
lines coupled with the importance of consumer involvement in
preventive care decisions, improved consumer education and
decision-making supports regarding evidence-based clinicalnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2010).
There are countless health messages delivered through com-
mercial channels, such as pharmaceutical marketing and health
plan advertising, and social marketing aimed at prevention and
health promotion (e.g., in tobacco, nutrition & physical activity,
and HIV/AIDS). Multiple converging messages can lead to infor-
mation overload and confusion for patients that may be difﬁcult
for practitioners to alleviate through brief counseling. At the same
time, some evidence-based health recommendations, such as
those embodied in the USPSTF clinical preventive services guide-
lines, can seem counterintuitive and lead to reactance or resis-
tance (Bensing, 2000; Santa, 2013). For example, the guidelines for
the Prostate Speciﬁc Antigen (PSA) testing and for mammography
screening have been controversial and elicited substantial public
debate, much of it against the USPSTF guidelines (Squiers et al.,
2011). These factors can affect patients’ ability to understand their
options, behavioral choices, and implications of treatment deci-
sions, and lead to uninformed decision making.
Communicating and promoting health behavior changes are
often easiest when there is solid clinical and scientiﬁc evidence to
support the argument for change. For example, the evidence for
health beneﬁts of smoking prevention or increased fruit and
vegetable consumption or condom use are clear-cut (Fitzgibbon
et al., 2007). In these cases, practitioners can add value to patient
decision making by providing a trusted source of additional
information that can motivate behavior change (Evans, 2006).
However, in cases where scientiﬁc information about health
behavior is lacking or uncertain, practitioners’ advice may seem
contrary to consumers’ expectations or desires. Many medical
decisions are probabilistic (i.e., outcomes are not certain and there
are beneﬁts and risks associated with prevention and treatment
options) and thus require knowledge acquisition and informed
decision-making rather than behavior change in response to per-
suasive social marketing messages (Jimison & Sher, 2000). Clinical
preventive services, where the medically recommended decision
in some cases may be counterintuitive (i.e., to not obtain a PSA
test), are a prime example of such decisions. Identifying the best
information to communicate, and in what manner, becomes
essential in order to promote informed and well advised patient
decision-making (Evans & McCormack, 2008; Grimshaw, Shirran,
& Thomas, 2001)
Lantz, Evans, Mead, Alvarez, and Stewart (2016) conducted a
national survey of consumers to understand individual-level fac-
tors that may be useful in the design of communication strategies
to increase knowledge and positive attitudes about evidence-
based guidelines for clinical preventive services (including the
USPSTF), and to reduce uncertainty among patients when guide-
lines change or are controversial (Lantz et al., 2016; Steinman,
Bero, & Chren, 2006; Evans, Uhrig, Davis, & McCormack, 2009).
This study found that 36.4% of adults knew that the Affordable
Care Act requires insurance companies to cover proven preventive
services without cost sharing but only 7.7% had heard of the
USPSTF. Most respondents agreed that research/scientiﬁc evidence
and expert medical opinion are important for the creation of
guidelines, and that clinicians should follow them. However when
presented with patient scenarios in which a physician made a
guideline-based recommendation against a cancer screening test,
less than 10% believed that this recommendation alone was suf-
ﬁcient for patient decision making. Clearly, different kinds of
information, as well as new and more persuasive means of mes-
sage presentation, are needed to assist patients in making
informed decisions and choosing to follow guidelines in their care.
In order to design more effective messages to promote patient
adherence to clinical preventive service guidelines, more research
is needed on the framing of messages and on how to increasemessage receptivity (O'Keefe & Jensen, 2007; Evans, Davis,
Umanzor, Patel, & Khan, 2011). Framing represents the manner in
which messages are presented, the salient information presented,
and the depiction of beneﬁts or consequences of acting or not
acting on the message (Rothman, Bartels, Wlaschin, & Salovey,
2006; Gallagher & Updegraff, 2012). Framing has been found to be
important because messages presenting nearly identical informa-
tion but in different frames can have variable effects on health
behavior (Gallagher & Updegraff, 2012). For example, consider the
difference between the beneﬁt, or gain-framed, message that
“preventive services can make you healthier” and the con-
sequence, or loss-framed, message that “preventive services can
prevent negative health effects.” These messages convey much the
same information but have different frames.
Message receptivity (MR) is a construct that represents rational
and affective reactions to messages (Dillard, Shen, & Vail, 2007).
Health communication studies have established measures of
“receptivity” to public service advertising that capture audiences’
subjective appraisals of message persuasiveness, believability, and
other aspects of cognitive processing (Biener, McCallum-Keeler, &
Nyman, 2000; Palmgreen, Lorch, Stephenson, Hoyle, & Donohew,
2007). These measures have been shown to predict changes in
attitudes toward the subject matter of advertisements (Evans, Yan,
& Datta, 2012; Niederdeppe, Davis, Farrelly, & Yarsevich, 2007).
The current study used these same measures, based on a validated
scale from the lead author’s previous research (Evans et al., 2011,
2012).
The present population-based study was a randomized
experiment conducted online to test reactions to messages
intended to promote the importance, understanding, and adher-
ence to preventive services screening guidelines. The speciﬁc
guidelines tested were for the PSA and Pap test screening. The
study had two objectives: (1) General testing of reactions to and
understanding of USPSTF guidelines, and (2) a randomized con-
trolled experiment in which a sub-sample of eligible participants
were randomized to a speciﬁc message condition, completed a
baseline questionnaire, and were followed up 8 weeks later to test
reactions to messages to promote PSA and Pap test preventive
services recommendations. The overall goal was to experimentally
test which message frames about speciﬁc guidelines generate the
most receptivity between a baseline and 8-week follow up and
best encourage people to form intentions to follow guidelines in
their own health care.Methods
Overview
The overall target population consisted of the following:
(1) non-institutionalized adults age 18 and over residing in the
United States, (2) a subsample of women aged 65 or younger, (3)
and a subsample of men aged 40 or older. Data were collected by
Gfk Custom Research, an online research panel. Current members
of the panel meeting criteria were randomly selected and recrui-
ted to participate in the study, as described in detail below.
In order to qualify for the research, participants were presented
with a consent form and asked whether they agreed to participate.
If they consented to participate, they were then shown the ques-
tionnaire. Those who chose not to participate (selecting “no” to the
consent) were excused.
Sample and data collection
We recruited a total of 5032 members of the GfK panel. Of
these, 3119 responded (62.0% completion rate) and 2923 were
Table 1
Message testing experimental design.
Message frame Guidelines tested (sample sizes per condition)
Pap test
(pre-test)
PSA (pre-
test)
Pap test
(post-test)
PSA (post-
test)
Gain 319 417 243 334
Loss 368 393 259 311
Both (balancing gain and
loss)
413 411 287 296
Total 1100 1221 789 941
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completed the initial questionnaire (93.7% eligibility rate). A total
of 2401 were eligible for the message testing experiment, 2321
(96.7%) consented, were randomized to a message condition, and
completed the baseline message testing questionnaire. A total of
1730 completed the follow up (74.5% follow up rate). GfK used an
equal probability selection method (EPSEM) sampling procedure.
To ensure that the sample for this study reﬂected EPSEM results, a
standardized sample weighting methodology was employed
(Dennis, 2010). GfK used data from the latest March supplement of
the Current Population Survey (CPS) along several geo-
demographic dimensions, including race/ethnicity, age, gender,
and location. This way, the weighted distribution of KP perfectly
matches that of the US adult population. The weighting metho-
dology is available online: (http://www.gfk.com/Documents/GfK-
KnowledgePanel-Design-Summary.pdf).
To sample the population, GfK targeted households from its
KnowledgePanel, a probability-based web panel designed to be
representative of the United States. Panel members are randomly
recruited through probability-based sampling, and households are
provided with access to the Internet and hardware if needed. GfK
recruits panel members by using address-based sampling meth-
ods. Once household members are recruited for the panel and
assigned to a study sample, they are notiﬁed by email for survey
taking, or panelists can visit their online member page for survey
taking (instead of being contacted by telephone or postal mail).
Instrument and measures
The initial questionnaire completed by all 2923 adults focused
on participant knowledge, attitudes, and beliefs about health care,
sources of health information, and beliefs about the importance
and perceived understanding of the USPSTF guidelines, and health
care coverage and practices (e.g., frequency of Doctor visits). These
items were developed through a prior study published by the
research team (Lantz et al., 2016). The initial questionnaire took
approximately 10 min to complete and included 30 questions. GfK
provided the investigators with detailed sociodemographic infor-
mation on the sample, which was used in the analysis.
After completing the initial questionnaire, and during the same
online GfK survey session, participants were screened for elig-
ibility for the message testing experiment: Qualiﬁed women aged
65 or younger (to test Pap test messages), and qualiﬁed men aged
40 or older (to test PSA messages). These eligibility criteria were
used to include only those women for whom the Pap test USPSTF
guidelines would be applicable, and only those men for whom the
PSA test guidelines would be applicable.
Eligible participants were randomly assigned to 1 of 6 message
testing experimental conditions, as shown in Table 1 (n¼ 2321).
Following recent research on differences in response to gain and
loss framed messages, we developed messages that were based on
content about the individual beneﬁts/consequences of following/
not following the speciﬁc guidelines.
The message testing experiment questionnaire was 15 min long
and included 45 questions, including speciﬁc questions about
attitudes and beliefs regarding either the PSA or Pap test guide-
lines, reactions and receptivity to speciﬁc messages concerning
each message presented, and resulting self-efﬁcacy, outcome
expectations, and other attitudes, beliefs, and intentions to con-
sider and follow the guidelines in personal health care. All ques-
tions were derived from validated scales used in the investigators’
previous research (Lantz et al., 2016; Evans et al., 2011). Speciﬁ-
cally, these scales have been found to be predictive of outcomes in
previous message testing experiments (Evans et al., 2011), and
were adapted by the research team to the speciﬁc content of
preventive services adherence (i.e., the stems of the validatedquestions were paired with response options concerning pre-
ventive services) and tested in a previous study (Lantz et al., 2016).
Scales measured level of agreement (e.g., on a scale from strongly
agree to strongly disagree, I am conﬁdent that I can consistently
follow the recommendations in this message) or as a dichotomous
yes/no, where appropriate (e.g., Will you follow the recommen-
dations in this message in your future health care decisions?). The
questions regarding speciﬁc messages were all framed in terms of
what the individual participant would do if they were in a situa-
tion of deciding whether to follow speciﬁc guidelines in their own
health care.
Within each message condition, the questionnaire included a
speciﬁc vignette that described an imaginary life situation and
then within that context a series of three potential messages about
making a preventive services utilization decision to take or not
take the PSA or Pap test framed in terms of either gain, loss, or a
balance of gain and loss. The vignettes were randomly assigned to
each participant and then messages presented in a randomly
assigned sequence. Finally, for each message frame presented,
respondents were asked if they would actually follow the guide-
line in deciding about their own health care given the vignette
presented.
Message testing design
The basic design of the message testing experiment was to
compare gain-framed, loss-framed, and balanced (beneﬁts and
consequences both communicated) clinical preventive service
messages for both the Pap test and PSA test. The design summary
is shown in Table 1 below.
Eight weeks after the baseline assessment, participants who
completed message testing baseline (ie, those eligible and con-
sented to one of the 6 experimental conditions only) were invited
to log in to the GfK survey web page again and complete a follow
up questionnaire. The follow up contained the same questions, and
again randomly presented the same sequence of vignettes/
assigned to get these messages frames shown to that participant at
the message testing experiment baseline. The vignettes/message
frames were presented again to stimulate respondents and remind
them of the messages they were asked to consider at baseline,
following previous methods employed by the research team. The
survey included additional questions asking whether the respon-
dent has searched online, or through other sources, for additional
information about the USPSTF, for information about speciﬁc
guidelines, and whether they had taken other actions such as
speaking to their doctor about USPSTF and/or speciﬁc guidelines
(latter questions conditioned on whether the respondent had the
opportunity to do so between pre-test and post-test).
For the PSA conditions, only men were randomly assigned to
get these messages. As noted earlier, men from the initial
population-based sample who were under age 40 (i.e., for whom
no organization recommends PSA screening) were dropped from
the message testing experiment. All others were randomized to
Table 2
Factor analysis for importance and understanding of guidelines.
Importance and understanding of guidelines Factor loadings
Factor 1 Factor 2
How would you rate your understanding of preventive
care?
0.1829 0.7422
How important is preventive care for your own per-
sonal health?
0.7077 0.3732
How important is preventive care for your family's
health?
0.7333 0.3466
How would you rate your understanding of “guide-
lines” for preventive care?
0.2695 0.6974
How important are guidelines to you for your own
personal preventive care decisions?
0.8477 0.1588
How important are guidelines for preventive care
decisions for your family?
0.8568 0.1331
Scale Reliability Coefﬁcient (Cronbach's Alpha/Pear-
son Correlation*)
α¼0.8861 ρ¼0.7981
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were randomly assigned to get these messages. Women from the
initial sample who were over age 65 (for whom Pap test guidelines
are more nuanced) were dropped from the experiment. The
remaining samples of men and women were randomized to the
gain/loss/balanced PSA and Pap test conditions, respectively.
The study protocol was reviewed and determined to be exempt
on May 8, 2014 by The George Washington University Institutional
Review Board (approval #041446).
Preventive services messages
Messaging consisted of an initial “vignette,” or scenario, in
which the patient was visiting their doctor. Vignettes described: (i)
source of the message (e.g., physician, friend, etc.), (ii) setting, and
(iii) other information about the respondent's life (e.g., ever pre-
viously had cancer, know someone who did). For example, this
was the description for the Pap test condition:
“You just found out that your best friend was diagnosed with
cervical cancer. You remember that you had a Pap test (also
called a Pap smear) after your last doctor visit about 1 year ago,
but you are worried and immediately call your doctor to make
an appointment for another Pap test. Your doctor tells you that
based on your personal history you are not at high risk for
cervical cancer, and that Pap tests are only recommended for
women your age every 3 years. You should wait another 2 years
to get your next Pap test. She provides you with written
information and points you to resources including Websites
that describe the guidelines and suggests that you review
them. You decide that you will go search for more information
on the Pap test.
After meeting with the doctor, you go to a health care website
that you trust and look up information on the Pap test. On the
Website home that describes the guidelines, you read the fol-
lowing message…”
Following this overall description was a series of three, one-
paragraph descriptions of the beneﬁts and consequences or a
combination of beneﬁts and consequences (depending on whether
the participant was in the gain, loss, or balanced condition) of
following or not following the health care recommendations
contained in the guidelines, presented in narrative text with no
other enhancements. There was a distinct series of three
descriptions for each study message condition. Each series of
descriptions was worded in a nearly identical manner, with the
exception of presentation of beneﬁts, consequences, or a combi-
nation of these factors that only the frame varied between mes-
sages. To avoid potential effects of message sequencing on out-
comes
(Niederdeppe et al., 2007), the order of presentation of the three
paragraph descriptions was randomized for participants within
each condition.
Data analysis
Descriptive statistics (means, percentages, standard errors)
were calculated for all measured variables collected on the full
sample of initial population-based questionnaire participants. All
subsequent data analysis was conducted on the message testing
participants and focused on the experimental results. Exploratory
factor analysis was performed to examine participant beliefs and
norms around preventive screening methods. These factors were
then utilized as scale variables in regression models, with inde-
pendent factors identiﬁed for “understanding of content” and
“valuing importance of preventive care”.We estimated mixed effect logistic regression models for the
entire sample (both PSA and Pap test messaging conditions) to
examine the effect of participant reaction to messages and
understanding of content on whether they intend to consider and
follow guidelines in their preventive care decision-making pro-
cess. Change in receptivity from baseline to follow up was mod-
eled as an interaction term in a ﬁxed effect model, with the factors
described above, as well as the participant’s subjective belief of
their own cancer risk, included as additional ﬁxed effect covari-
ates. A random intercept term, and a random slope term for the
participant’s gender, was also included in each model.
Mixed effect logistic regression models were constructed in a
similar manner to examine the effect of treatment condition
(receiving a gain, loss, or balanced message) and other beliefs on
positive change in outcomes from baseline to follow up around
behaviors such as seeking new information and in considering and
following USPSTF guidelines. Stata version 12 (College Station, TX)
was used in all analyses.
We used complete case analysis methods to handle missing
data. Only those respondents with both baseline and follow up
message testing experiment data were used in the mixed effect
model. We separately conducted paired t-tests to examine any
signiﬁcant differences between the baseline and follow up mes-
sage testing experiment samples and found none.Results
The initial population-based sample of 2923 was 77.0% White,
12.2% Hispanic, 8.3% African American, and 2.5% other. A total of
54.4% of participants were male, 34% had a Bachelor’s degree or
higher, 71.4% were age 45 or older, 61.6% were currently married,
and 85.8% lived in a designated metropolitan area (DMA). A total of
59.1% reported working full time and 79.5% reported having home
Internet access (without receiving it from GfK, which provided
Internet if necessary to participate in the panel).
All subsequent results reported below are for the message
testing experimental sample of 2321 eligible participants. As
noted, exploratory factor analysis was conducted on the variables
for participant beliefs about the “importance” and their “under-
standing” of preventive services guidelines and for the message
receptivity scale. Tables 2 and 3 summarize the results. Overall, we
identiﬁed separate factors for understanding and importance, and
a message receptivity factor, and used these in subsequent
analyzes.
Next, we estimated mixed effect regression models to examine
the effects of change in message receptivity from message testing
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reported they would take regarding future preventive services in
the randomized experiment. These results are shown in Table 4.
An increase in message receptivity from baseline to follow up was
associated with higher odds of seeking more information on the
Internet (OR¼5.52, CI¼3.73, 8.17; po0.001) and on intention to
speak to a health care professional about preventive services
(OR¼2.26, CI¼1.44, 3.55, po0.001).
Additionally, the factor of understanding of preventive services
was associated with higher odds of intention to speak to a health
care professional about them (OR¼2.467, CI¼1.944, 3.13,
po0.001). Finally, the factor of belief in importance of preventive
services was associated with higher odds of seeking information
about them online (OR¼1.29, CI¼1.10, 1.51, p¼ .002) and inter-
estingly in lower odds of intention to speak to family and friends
about them (OR¼0.80, CI¼0.67, 0.940, po0.007).
In a ﬁnal set of mixed effect regression models, we estimated
the effect of experimental message framing condition (gain, loss,
or balanced PSA screening or Pap test) on reported future actions
regarding preventive services (Table 5). We found an increase in
intention to talk to family and friends about preventive services
among loss group participants in both the PSA and Pap test con-
ditions (OR¼1.40, CI¼1.018, 1.95, po0.045). No other treatment
condition effects were observed.
The results also revealed several effects of beliefs about pre-
ventive services, as well as personal history and characteristics, on
responses to messages. Participants who perceived their risk of
cancer as being lower than average (OR¼2.06 CI¼1.33, 3.19,
po0.001) were more likely to say that the messages in their
condition (both PSA and Pap test) “grabbed their attention,” a
measure of receptivity. The factor representing the understanding
of the content of preventive services messages was associated withTable 3
Factor analysis for message receptivity.
Message receptivity PSA PAP
Would you say the message grabbed your attention?
(overall factor loading¼0.7133)
0.6881 0.7423
Would you say the message gave you good reasons to
seek more information about PSA/PAP screenings
(overall factor loading¼0.6082)
0.5805 0.6383
Would you say this message said something important
to you? (overall factor loading¼0.7655)
0.7721 0.7552
Scale Reliability Coefﬁcient (Cronbach's Alpha)
(overall factor loading¼0.7634)
α¼0.7427 α¼0.7832
Table 4
Message receptivity and outcomes.
Please indicate which of the following
Seek more information on
internet (n¼2321)
P
Receptivity score 5.524nnn (3.734, 8.173) o0.
Overall improvement from baseline to follow
up
0.710 (0.351, 1.437) 0.341
Change from baseline to follow up with
higher receptivity score
0.819 (0.487, 1.378) 0.45
Lower than average risk of cancer 1.227 (0.823, 1.829) 0.316
Higher than average risk of cancer 1.108 (0.851, 1.443) 0.44
Factor of understanding content 1.138 (0.929, 1.395) 0.210
Factor of importance of preventive care 1.286nn (1.094, 1.511) 0.00
Odds ratios shown
n ¼po .05.
nn ¼po .01.
nnn ¼po .001.higher odds of seeking more information on the internet,
(OR¼1.39, CI¼1.13, 1.70, po0.001) intention to speak to a health
professional (OR¼2.06, CI¼1.56, 2.72, po0.001), as well as indi-
cation that messages in their condition grabbed their attention
(OR¼3.68, CI¼2.89, 4.70, po0.001). Finally, the factor of belief in
the importance of preventive care was associated with higher odds
of seeking more information on the internet (OR¼1.24, CI¼1.05,
1.45, p¼ .009) and lower odds of speaking to family and friends
(OR¼0.78, CI¼0.66, 0.92, p¼0.003) and of indicating messages in
their condition grabbed their attention (OR¼0.75, CI¼0.63, 0.90,
po0.001). Note that for these logistic regression analyzes, the
reference group is the gain frame message condition.Discussion
The research ﬁndings presented here build upon the very
limited evidence base on messages to promote consumer under-
standing and adherence to clinical preventive services guidelines.
As noted earlier, consumers are generally not well informed about
the importance of evidence-based medical decision making in
general, and clinical preventive services in particular (Lantz et al.,
2016; Steinman et al., 2006). However, there is little prior research
regarding how expert guidelines or recommendations are framed
in health communications (Evans et al., 2009). The current
research helps to shed light on two important areas of research
interest: (1) developing, reﬁning, testing, and evaluating patient-
centered approaches for translating evidence-based care into
health care practice in ways that account for individual patient
preferences for various outcomes; and (2) identifying, testing, and/
or evaluating methods that can be used to assess the patient
perspective when researching behaviors, lifestyles, and choices
within the patient’s control that may inﬂuence their outcomes
(Lantz et al., 2016).
This research also provides preliminary information to help craft
effective communications regarding confusing and/or controversial
guidelines for preventive behaviors that assist patients in con-
sidering “what are my options and what are the beneﬁts and harms of
those options?” While the controversial guidelines being considered
in this particular research are about cancer screening, our ﬁndings
are signiﬁcant as they may apply to other types of USPSTF recom-
mendations and patient decisions (Evans & McCormack, 2008).
As noted earlier, while not an explicit message frame (Gallagher
& Updegraff, 2012), message receptivity has been shown to be an
important immediate effect of exposure to health messages that
predicts future behavioral and related outcomes (Biener et al.,actions you plan to take in the future regarding preventive services.
Talk to a health professional
(n¼2321)
P Talk to friends or family
(n¼2321)
P
001 2.256nnn (1.435, 3.548) o0.001 1.228 (0.813, 1.855) 0.329
1.448 (0.584, 3.586) 0.424 1.574 (0.740, 3.349) 0.239
3 1.236 (0.678, 2.252) 0.489 1.234 (0.715, 2.132) 0.450
0.831 (0.479, 1.442) 0.511 1.057 (0.678, 1.648) 0.806
6 1.054 (0.749, 1.482) 0.764 0.964 (0.719, 1.292) 0.804
2.156nnn (1.615, 2.877) 0.000 0.966 (0.773, 1.207) 0.762
2 1.253n (1.023, 1.535) 0.029 0.795nn (0.672, 0.940) 0.007
Table 5
Message frames and outcomes. (OR and 95% conﬁdence interval and P values shown)
Seek more information on inter-
net (n¼2321)
P value Talk to a health professional
(n¼2321)
P valve Talk to friends or family
(n¼2321)
P value
Received loss pap or PSA message (gain¼ref) 1.095 (0.762, 1.574) 0.623 0.612n (0.394, 0.953) 0.030 1.486n (1.002, 2.202) 0.049
Received balanced pap or PSA message
(gain¼ref)
0.982 (0.687, 1.403) 0.919 0.801 (0.518, 1.241) 0.321 1.256 (0.854, 1.849) 0.247
Change from baseline to follow up in loss
group
0.864 (0.624, 1.196) 0.379 0.899 (0.594, 1.361) 0.615 1.574n (1.094, 2.264) 0.014
Change from baseline to follow up in gain
group (gain¼ref)
1.127 (0.708, 1.792) 0.614 1.428 (0.817, 2.497) 0.211 0.697 (0.416, 1.166) 0.169
Change from baseline to follow up in balanced
group (gain¼ref)
1.113 (0.707, 1.751) 0.644 1.239 (0.689, 2.227) 0.474 0.647 (0.394, 1.062) 0.085
Lower than average risk of cancer 1.470 (0.970, 2.226) 0.069 1.132 (0.651, 1.967) 0.660 1.133 (0.729, 1.760) 0.578
Higher than average risk of cancer 1.122 (0.857, 1.471) 0.402 1.233 (0.876, 1.735) 0.230 0.997 (0.745, 1.334) 0.984
Factor of understanding content 1.387nn (1.134, 1.698) 0.001 2.061nnn (1.563, 2.719) 0.000 0.972 (0.787, 1.200) 0.789
Factor of importance of preventive care 1.236nn (1.053, 1.450) 0.009 1.215 (1.000, 1.476) 0.050 0.781nn (0.663, 0.919) 0.003
Would you say the mes-
sage grabbed your
attention?
P value If I consistently follow the recommendations
in this message, I will have better health
P value How likely are you to follow the U.S. Preventive
Services Task Force guidelines in regard to your
own use of preventive care
P value Message said some-
thing important to you
P value
Received loss pap or PSA message
(gain¼ref)
0.708 (0.476, 1.054) 0.089 0.993 (0.581, 1.699) 0.980 1.238 (0.858, 1.785) 0.255 0.685 (0.444, 1.055) 0.086
Received balanced pap or PSA
message (gain¼ref)
0.855 (0.580, 1.260) 0.429 1.027 (0.616, 1.712) 0.919 1.686nn (1.178, 2.413) 0.004 0.974 (0.638, 1.487) 0.902
Change from baseline to follow up
in loss group
0.847 (0.590, 1.216) 0.369 0.993 (0.623, 1.583) 0.978 1.287 (0.934, 1.772) 0.123 1.006 (0.681, 1.487) 0.975
Change from baseline to follow up
in loss group (gain¼ref)
1.457 (0.878, 2.421) 0.146 0.971 (0.504, 1.871) 0.930 0.863 (0.542, 1.374) 0.534 1.204 (0.691, 2.098) 0.511
Change from baseline to follow up
in balanced group (gain¼ref)
1.505 (0.924, 2.449) 0.100 1.132 (0.585, 2.190) 0.713 0.757 (0.480, 1.193) 0.230 1.210 (0.709, 2.063) 0.484
Lower than average risk of cancer 2.055nn (1.325, 3.186) 0.001 0.615 (0.338, 1.120) 0.112 1.213 (0.788, 1.869) 0.381 1.315 (0.822, 2.104) 0.253
Higher than average risk of cancer 0.897 (0.676, 1.190) 0.450 1.324 (0.901, 1.944) 0.153 0.885 (0.678, 1.154) 0.365 0.786 (0.581, 1.063) 0.118
Understanding content factor 3.679nnn (2.885, 4.691) 0.000 4.496nnn (3.194, 6.329) 0.000 3.334nnn (2.679, 4.148) 0.000 5.230nnn (3.969, 6.892) 0.000
Importance of preventive care
factor
0.753nn (0.633, 0.895) 0.001 0.828 (0.657, 1.044) 0.110 1.238nn (1.059, 1.448) 0.007 0.683nnn (0.563, 0.829) 0.000
n ¼po .05.
nn ¼po .01.
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consistent with previous message receptivity research, and ﬁnds
that it is associated with a range of effects on preventive services
outcomes (Niederdeppe et al., 2007). Generally, higher receptivity
and an increase in receptivity between baseline and follow up in
our experiment were associated with greater intentions to seek
more information about preventive services. Receptivity to mes-
sage stimulates interest in knowing more about preventive ser-
vices, which presumably would lead to more informed decision-
making. This was true both with regard to speciﬁc PSA and Pap
test messages. A natural conclusion is that messages need to be
designed to maximize receptivity. The question is how best to
accomplish this.
Second, we found that understanding and belief in the impor-
tance of preventive services as measured in this research
(1) represent scale variables that can be used in future research,
and (2) are highly predictive of preventive services outcomes.
Generally, having greater understanding of guidelines predicts
more interest in gaining information about preventive services.
This in turn would naturally lead to more informed decision
making. Again, this was true both with regard to speciﬁc PSA and
Pap test messages. The question of course is how best to increase
understanding.
However, we found mixed results for the belief in importance
factor. In some cases, such as speaking to a health care profes-
sional, it predicted greater likelihood of future action. However, in
other cases such as speaking to family and friends and a message
grabbing the individual’s attention, it predicted lesser likelihood of
the action. One interpretation is that this indicates belief in
importance calls for stronger and more deﬁnitive action on the
part of the individual. In any case, increasing belief in the impor-
tance of clinical preventive services appears to be an importance
objective, but how best to accomplish it?
Our experiment was designed to investigate the inﬂuence of
different frames on message receptivity, understanding, and belief
in importance of guidelines. As such, it was a study of the com-
parative effectiveness of messages. We found that the loss frame
was associated with increased intentions to speak to family and
friends about preventive services. Given that family and friends
would presumably be among the “ﬁrst stops” as an individual
becomes more informed about guidelines and preventive services,
this may indicate the loss-framing increases contemplation (rather
than action) to make informed decision and follow guidelines in
personal care. Following the Transtheoretical model, promoting
contemplation is an important step, but an early one that would
not alone be sufﬁcient to change behavior (Prochaska, DiClemente,
& Norcross, 1992). Also, a balanced message frame was associated
with likelihood to follow U.S. Preventive Services Guidelines.
However, no other framing effects were observed in the experi-
mental study, and no effects were observed over time in change of
beliefs relative to treatment groups.
The lack of other signiﬁcant framing effects suggests two
competing hypotheses that deserve further investigation. First, the
relatively information-poor, brieﬂy presented, text-only messages
used in this experiment are insufﬁciently persuasive and infor-
mative to lead to behavioral effects. Previous research suggests
that graphic, interactive, and repeat presentation (ie, higher
dosage) of messages is required to produce meaningful effects
(Evans et al., 2009; Hornik, Jacobsohn, Orwin, Piesse, & Kalton,
2008). Because there is scant evidence in the preventive services
and informed decision making literature on these points (Evans
et al., 2009), more research is needed to test whether enhanced,
information rich messages would have greater effects on pre-
ventive services outcomes.
Second, it is possible that messaging in simple text mode,
without elaboration or other sources of stimuli, is simplyinsufﬁcient to have behavioral effects. Based on work in public
health promotion, such as tobacco control (Centers for Disease
Control and Prevention, 2015; Evans, Davis, & Farrelly, 2008), it
may be that multiple types of interventions involving the various
levels of social ecology (e.g., interpersonal, community, media,
policy) are required to produce meaningful effects on preventive
services outcomes. Field based studies to examine larger cam-
paigns to change health care consumer behavior would be needed
to examine this important hypothesis.
There are some important limitations to this research. First,
while we gathered a nationally representative sample using the
GfK panel, and employed a randomized experimental design,
testing reactions to preventive services messages outside of a
health care environment, and outside contexts on which con-
sumers focus on health care issues is somewhat artiﬁcial. The
study has high internal validity but relatively low external validity.
Field-based studies in health care, or health decision-making,
settings would be needed to achieve higher external validity.
Second, since little is known about how to construct preventive
services messages, we had little to go on in constructing effective
message frames and creating persuasive content. Our ﬁndings
reﬂect some progress in understanding these factors, but also
signiﬁcant gaps. It is not clear whether framing alone can produce
meaningful preventive services decision-making effects. More
research is needed on the framing and message content factors
noted above to isolate these effects. Additionally because our study
only targeted consumers, we cannot comment on the potential
contributions of providers in framing clinical preventive services
messages. Future research that includes provider input on framing
is needed.Conclusion
Prior research demonstrates that health care consumers gen-
erally are not well informed about evidence-based care and that
they hold beliefs and values that interfere with optimal decisions,
including the belief that more care is almost always better
(Kivinieme & Hay, 2012; Allen, Solberg Nes, Marnach, Polga, &
Jenkins, 2012). Additionally, attempts to inform consumers about
treatments and tests that are overused and often unnecessary
(such as the Choosing Wisely campaign) face the difﬁcult chal-
lenge of telling people “what not to do.” (Briss, Rimer, & Reilley,
2004)
In other areas of health behavior and health care promotion,
use of elaborated messaging using graphic, video, and narrative
story (e.g., a doctor and patient communicating successfully about
guidelines) and case study methods have been shown to be highly
effective (Harmon, 2011). Yet no such approach has been applied
in promotion of preventive services guidelines in health care
(Lantz et al., 2016). Further, no comparative effectiveness research
has been conducted on the relative beneﬁts of speciﬁc enhance-
ments and elaborations, such as video versus narrative text-based
messages to promote patient-provider communication about
preventive services (Andrade, Evans, Edberg, Cubana, & Cleary,
2015). This study starts the process of ﬁlling those gaps and
demonstrate comparative effectiveness of messages for PSA
screening and Pap test decision making (Hoffman, Elmore,
Fairﬁeld, & Gerstein, 2014).
Future research should examine how practitioners can best
communicate with patients about following preventive services
guidelines, both individually and in combination with other stra-
tegies for provider education (e.g., Continuing Medical Education,
publications) and consumer education (e.g., direct-to-consumer
communication and marketing) (Steinman et al., 2006).
W.D. Evans et al. / SSM -Population Health 1 (2015) 48–55 55To develop these strategies for practitioners, more experiments
in which messages are delivered and reactions measured under
controlled conditions are needed to demonstrate how messages
can best be changed. This study suggests that message receptivity
could be a mediating variable between message framing and
attitudes or adherence to guidelines. Future research should
examine multiple pathways through which preventive services
messages may inﬂuence adherence outcomes.Acknowledgments
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